|
|||||
|
|
High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy |
|
| Authors: | Li‐Ru He Meng‐Zhong Liu Bin‐Kui Li Wei‐Hua Jia Ying Zhang Yi‐Ji Liao Yang‐Chao Chen Lan‐Jun Zhang Xin‐Yuan Guan Yi‐Xin Zeng Hsiang‐Fu Kung Dan Xie |
| Affiliation: | 1. State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat‐Sen University, Guangzhou, China;2. Department of Radiotherapy, Cancer Center, Sun Yat‐Sen University, Guangzhou, China;3. State Key Laboratory of Oncology in South China, The Chinese University of Hong Kong, Hong Kong, China;4. State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat‐Sen University, Guangzhou, ChinaFax: +86‐20‐87343170 |
| Abstract: | |
| Keywords: | esophageal squamous cell carcinoma EZH2 chemoradiotherapy prognosis immunohistochemistry |